Downloaded from on June 5, 2014 - Published by group.bmj.


Original paper

Role of acupuncture in the
management of diabetic painful
neuropathy (DPN): a pilot RCT
Adam P Garrow,1,2 Mei Xing,1,3 Joanne Vere,1 Barbara Verrall,1
LiFen Wang,1,4 Edward B Jude1,5


Tameside Hospital NHS
Foundation Trust, Diabetes
Centre, Tameside General
Hospital, Ashton-Under-Lyne,
Greater Manchester, UK
The University of Manchester,
School of Nursing, Midwifery
and Social Work, Manchester,
Greater Manchester, UK
The University of Salford,
School of Health Sciences,
Salford, UK
Christie Hospital NHS Trust,
Manchester, Greater Manchester,
School of Clinical and
Laboratory Sciences, The
University of Manchester,
Manchester, Greater Manchester,
Correspondence to
Dr Edward Bernard Jude,
Tameside Hospital NHS
Foundation Trust, Diabetes
Centre, Tameside General
Hospital, Ashton-Under-Lyne,
Greater Manchester OL6 9RW,
Received 17 November 2013
Revised 7 February 2014
Accepted 10 February 2014
Published Online First
21 March 2014

To cite: Garrow AP, Xing M,
Vere J, et al. Acupunct Med


Aims To examine the role of acupuncture in the
treatment of diabetic painful neuropathy (DPN)
using a single-blind, placebo-controlled RCT and to
collect data that would be required in a future
definitive study of the efficacy of acupuncture in
Methods 45 patients were allocated to receive a
10-week course either of real (53%) or sham
(47%) acupuncture. Five standardised acupuncture
points on the lower limb of each leg were used in
the study: LR3, KI3, SP6, SP10 and ST36. Outcome
measures included the Leeds Assessment of
Neuropathic Symptoms and Signs (LANSS) scale,
lower limb pain (Visual Analogue Scale, VAS);
Sleep Problem Scale (SPS); Measure Yourself
Medical Outcome Profile (MYMOP); 36-item Short
Form 36 Health Survey and resting blood pressure
Results Over the 10-week treatment period, small
improvements were seen in VAS −15 (−26 to
−3.5), MYMOP −0.89 (−1.4 to −0.3), SPS −2.5
(−4.2 to −0.82) and resting diastolic BP −5.2
(−10.4 to −0.14) in the true acupuncture group. In
contrast, there was little change in those receiving
sham acupuncture. A moderate treatment effect in
favour of active acupuncture was detected in
MYMOP scores −0.66 (−0.96 to −0.35) but nonsignificant effect sizes in LANSS Pain Scale −0.37
(−2.2 to 1.4), resting diastolic BP −0.50 (−3.0 to
1.99) and the SPS −0.51 (−2.2 to 1.16).
Conclusions We have demonstrated the
practicality and feasibility of acupuncture as an
additional treatment for people with DPN. The
treatment was well tolerated with no appreciable
side effects. Larger randomised trials are needed to
confirm the clinical and cost-effectiveness of
acupuncture in the treatment of DPN.
Trial registration number ISRCTN number:

Diabetic painful neuropathy (DPN) is a
distressing and disabling complication of

diabetes mellitus. A recent study showed
that nearly one-third of patients with type
2 diabetes have DPN.1 The causes of this
condition are not yet fully understood,
but age, duration of diabetes and diabetes
control have all been shown to be associated with DPN.1 Typical symptoms
include nocturnal burning or shooting
pains in the legs and feet, indicating
impairment or damage to small nerve
fibres. Symptoms often persist for years
and are associated with disrupted sleeping
patterns and a poor quality of life.2 No
treatment that can reverse the development or progression of diabetic peripheral
neuropathy is available.3 Treatment, therefore, relies on the use of medication to
manage the pain. The most commonly
prescribed drugs for DPN are tricyclic
Clinical trials have shown these drugs to
be effective in controlling the pain but
they have important side effects, including
dizziness and nausea. Up to two-thirds of
patients may have at least one side effect
from taking these drugs, of which 15%
will be serious enough for them to stop
taking the drugs, leaving them with no
effective treatment.4 A number of other,
non-pharmacological treatments have
been tried, including the application of
topical capsaicin and opsite film dressing.
Although there is some evidence that capsaicin can lead to a reduction in pain
score, the effectiveness of topical treatments is yet to be determined.5
Acupuncture has been shown to be
effective in treating back pain and shoulder
pain.6 7 There is also some evidence that it
may be beneficial in the management of
peripheral neuropathy and painful neuropathy in diabetes.8–10 However, the evidence to support this use of acupuncture is
deficient because of poor methodology,

Garrow AP, et al. Acupunct Med 2014;32:242–249. doi:10.1136/acupmed-2013-010495

Garrow AP. de qi and blood stagnation. kidney deficiency. The study also considered a range of different outcomes for their suitability for a future definitive clinical trial. defined as the absence of any two of sharp/blunt sensations (measured using a NeuroTip)14. The treatment allocation was revealed to the acupuncturists out of sight of the participants to ensure blinding. aged between 18 and 80 years. Acupunct Med 2014. and to derive point and variability estimates to inform future sample size calculations.8 9 17 18 The point location and depth of needle insertion were based on traditional acupuncture methods and good clinical practice. Study design Before the recruitment. opened only after enrolment. She has also been a senior lecturer in traditional Chinese medicine and acupuncture since 2001. The acupuncture treatments were carried out by any one of three trained acupuncturists who were either members of the British Acupuncture Council or the Acupuncture Association of Chartered Physiotherapists. The study was approved by the north west ethics committee (ref: 08/H1011/16A) and all patients gave written informed consent before taking part in the study.19 The depth of needle insertion varied according to point.32:242–249. impaired light touch (10 g monofilament)15 or a vibration perception threshold on either foot >25 V. with a clinical diagnosis of DPN and taking a prescribed drug for DPN were identified from primary and secondary care patient databases and invited to attend a screening visit held in the recruiting centre of a local district general hospital. which has been validated for use in randomised clinical trials. Original paper variability of treatment protocols and small sample sizes. LR3. on June 5.Published by group. most studies have concentrated on the analgesic properties of acupuncture. The chosen points are based on traditional Chinese medicine diagnosis for diabetes and neuropathy—that is. doi:10.bmj. Korea). A series of training sessions were carried out before the start of the study to allow practitioners to become familiar with the sham acupuncture devices and to standardise point location and technique. measured with a neurosthesiometer. SP10 and ST36 (figure 1).20 In brief. Other inclusion criteria were patients taking a prescribed drug for their neuropathic pain. having at least one palpable pedal pulse per foot. a computer-generated randomised list of numbers was prepared allocating participants to receive either real or sham acupuncture.13 The objective of this sham-controlled single-blind RCT was to examine the practicality and feasibility of integrating acupuncture into the management of lower limb painful neuropathy in diabetes. These acupuncture points have also commonly been used in other similar clinical studies. 2014 . Two of the acupuncturists (BV and LFW) were UK trained with nearly 10 years’ experience of treating patients in the NHS and in private practice.11 12 To date.Downloaded from aim. The allocation was placed inside sequentially ordered sealed opaque envelopes. et al. not having previously received acupuncture treatment for DPN. but was usually 0. the acupuncture practitioners were discouraged from discussing the treatments or previous results with the patients.25–2 cm).16 Data were collected between July 2008 and March 2010. The sham device used in the study was the Park sham device (Dong Bang Acupuncture Inc. a meta-analysis of 29 acupuncture RCTs in the treatment in chronic pain showed that acupuncture produces small but clinically relevant reductions in pain. To reduce the risk of observer bias. the sham needle. ISRCTN Number: 39740785.5–1. being free of foot ulcers at the start of the study and having signs of peripheral sensory neuropathy. The third practitioner (MX) was trained in integrated medicine in China and has worked as a consultant doctor in Western and Chinese medicine. 243 . Weekly afternoon clinics were arranged allowing sufficient time for the collection of study outcome data and for the acupuncture treatments to be completed.5 cun (about 0. For example.1136/acupmed-2013-010495 Figure 1 Acupuncture points. PATIENTS AND METHODS Sixty-five patients with type 1 or type 2 diabetes.bmj. A total of five standardised acupuncture points on the foot and lower limb of each leg (total 10) were used in the study. both the real and sham disposable needles look identical.

including those taken for DPN. Sleep quality was assessed using the Sleep Problem Scale (SPS). the number of adverse events and losses to follow-up.1136/acupmed-2013-010495 . For each of the outcome measures.25 General health status was measured using the 36-item Short Form 36 Health Survey (SF-36).4 considered small effects. Outcome measures Power calculation and sample size As this was a feasibility study.21 After insertion. In addition. with values ≤0. which is in keeping with normal acupuncture practice. doi:10. a consultant in diabetes. Acupunct Med 2014. As outcome values were likely to be strongly correlated with baseline values. to determine whether the event was related to the acupuncture treatment. The instrument was developed specifically for use in studies of complementary medicine24 and collects information on symptoms considered by the patient to be important. The primary Garrow AP.4–0.32:242–249.29 244 Adverse event reporting At the beginning of each study visit. a primary outcome measure and a formal power calculation were not required.7 considered moderate and >0.31 RESULTS Study sample All patients were enrolled into the study within the 18-month target recruitment on June Original paper however.bmj. an effect size estimate comparing real and sham acupuncture groups was calculated as the difference between the 10-week mean values divided by the pooled SD. The protocol permitted changes in medication as required. a mental health score and a bodily pain score (BPS).30 Group differences between the means are presented together with their 95% CIs. SPS and SF-36 were completed at the baseline visit. Our target sample of 60 people was based on the recommendations of Lancaster et al.22 Although originally developed as a screening instrument. All patients with suspected adverse events received a referral appointment with the study principal investigator.Published by group. all patients had their blood pressure taken before and after treatment and completed a copy of the MYMOP and a VAS for pain.Downloaded from aim.bmj. there is now some evidence and growing interest in the potential benefits of acupuncture in the management of hypertension.19 The intervention consisted of a total of 10 weekly sessions during which diabetes and blood pressure management continued as normal. 0. As this was a feasibility study. We did not ask patients whether they felt de qi to avoid the risk of patients in the placebo group becoming unblinded to their treatment allocation. Baseline characteristics are presented using means and SDs and categorical data are presented as proportions. patients were asked if they had had any side effects as a result of the acupuncture treatment. with scores >12 indicating that neuropathic mechanisms are likely to be contributing to patients’ pain.7 considered large effects. Outcomes selected for this study were based on measures used in previous studies of DPN. Lower limb pain intensity was measured on a 100 mm Visual Analogue Scale (VAS). They were also informed that they would not be told which treatment they had received until all study visits had been completed. Any adverse events were recorded on the case report forms and reported to the principal investigator (EBJ) and the research and development department according to the hospital’s standard operating procedures.23 The instrument contains questions pertaining to five neuropathic sensory disturbance domains and two sensory examination items.27 28 As resting blood pressure is routinely measured in the diabetic clinic. et al.26 At each study visit. χ2 Tests were performed on categorical data and t tests on continuous variables. and the Measure Yourself Medical Outcome Profile (MYMOP) was used to measure changes in health over time. the needles remained in place for 30 min and both real and sham needles were manipulated after 15 min. Assessments of neuropathic pain were carried out using the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) Pain Scale. Before needling. the LANSS pain scale. 2014 . Last observation carried forward was used to replace missing values. All patients were provided with a patient information sheet which informed them that they were taking part in a randomised trial in which they could be treated with real acupuncture or an inactive treatment that looked like real acupuncture. systolic and diastolic blood pressures were recorded before each acupuncture treatment. The maximum score on the LANSS scale is 24. a sliding plastic tube is adhered to each of the acupuncture points to mask the allocation of needles from the patients. The analyses were conducted on an ‘intention-to-treat’ basis. patients were provided with a telephone number to report any concerns they had about the study. In addition. Statistical analysis We considered the availability and willingness of patients to be recruited. which produces three subscale scores: physical health score. Although the main focus of this study was to examine the benefits of acupuncture for the treatment of DPN. the LANSS has been used as an outcome measure in previous neuropathic pain RCTs. a short standardised measure of sleep disturbance. The proportions in each group showing at least a 25% improvement in LANSS and VAS pain scores were also compared. week 5 and week 10. analyses of covariance were carried out. is blunt and slides into the handle rather than penetrating the skin when the needle is tapped. a power calculation was not required.

suggesting that it is a safe treatment.32 This study has provided a model of how acupuncture can be easily incorporated into the routine management of people with DPN. Visual Analogue Scale.1) Male (%) 71 67 Type 2 diabetes (%) 95 96 Diabetes duration years (mean.5) *Light touch sensation assessed using a 10 g monofilament.9%) in the sham treatment group. A total of four patients in the active group and 10 patients in the sham group failed to complete the study (figure 2). Because of the small numbers.bmj. MYMOP. three adverse events were reported resulting in patients withdrawing from the study.4%) in the group receiving active treatment showed at least a 25% improvement in VAS pain intensity score compared with four of 31 (12. those in the sham group showed a 7. The patients who received active acupuncture were slightly older and also had higher levels of sensorimotor impairment. Measure Yourself Medical Outcome Profile. SD)‡ VAS pain score (median. one participant withdrew because she developed a localised swelling in her leg. The baseline demographic and clinical characteristics are displayed in table 1. the LANSS score improved by an average of 2. This report follows STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA) guidelines. we were unable to determine whether these differences influenced the results of the study. resulting in 59 being enrolled into the study. LANNS. Bias resulting from inadequacies in blinding could lead to exaggerated 245 . which was considered unrelated to the study.4) White British (%) 81 100 Married (%) 76 79 Retired (%) 52 63 At least one palpable pedal pulse on either 100 100 foot (%) Bilateral impaired sharp/blunt sensation (%)* 89 96 Bilateral impaired light touch sensation (%)† 30 29 Vibration perception threshold (VPT) (right) 27 (8. Blood Pressure. MYMOP score. et al.0 (9. None of the patients changed their neuropathic pain medication during the 10-week study period.7) (mean. IQR) 70 (50–80) 78 (70–90) LANNS pain scale (median. Forty-five (76%) patients completed a baseline and final assessment: 24 (53%) received active acupuncture and 21 (47%) sham acupuncture treatment.1136/acupmed-2013-010495 incidents of infections associated with the administration of acupuncture were seen or reported. DISCUSSION This is one of very few studies that have investigated the role of acupuncture in the management of lower limb DPN. SD) 78 (10.4 (1. six refused.bmj.2) 137 (14. and another withdrew as she felt that the acupuncture exacerbated her leg pain.2% deterioration in LANSS symptoms (table 2). Leeds Assessment of Neuropathic Symptoms and Original paper care medical staff and administrators supported the project and readily agreed to identify potentially suitable patients from the databases.2) Systolic BP (mean.1 (1. In contrast. Patients in the active acupuncture group showed a 16% improvement in LANSS score after acupuncture.Published by group. In the active acupuncture group. IQR) 13 (7–20) 12 (6–16) MYMOP (mean.1) 33 (10.0) 75 (9. No Table 1 Baseline characteristics of patients randomised into groups who received real or sham acupuncture treatment Characteristics Sham (n=21) Active (n=24) Age (mean. Of the 65 patients considered eligible. improvements over 10 weeks were found for VAS pain intensity.2 (7. Improvements were also seen for SF-36 physical component and BPS and systolic blood pressure.3) Diastolic BP (mean. In the group receiving active treatment. SPS and diastolic blood pressure. make the initial contact with the patients and send out the patient information sheets. resting blood pressure and SPS but these were much smaller than those found in the active treatment group. related to a chronic heart condition. Six of 24 (25%) patients in the active acupuncture group showed at least a 25% improvement compared with four of 21 (19%) in the sham group. ‡Vibration perception assessed using a neurothesiometer. In the sham group. In the analysis of covariance. Overall. Acupuncture was also well tolerated by patients with few if any side effects. SD) 11. 2014 .com on June 5. one participant developed chest pains while undergoing acupuncture treatment. SD) 63 (10. IQR) 15 (10–19) 14 (9–19) Sleep Problem Scale (median.3 unit improvement in SF-36 BPS (table 2).Downloaded from aim. SD) 131 (19. SD) 4. doi:10. the non-completion rate was in line with expectation but found to be higher amongst those allocated to receive sham treatment.8) 68 (11. One person in the sham group stopped taking their medication owing to low blood pressure. Adverse events In total. Two patients in the group receiving active acupuncture had their blood pressure medication stopped owing to low blood pressure and two patients had their medication dose increased. BP. The largest change seen in the sham group was a 6. Sham group participants also showed improvements in VAS score. Thirteen of 28 (46. †Impaired sharp blunt sensation assessed using a NeuroTip.1 points more in the treatment group than the sham group which would be considered as a moderate treatment effect (table 3).2) 12. Garrow AP. The study was carried out on a fairly typical sample of patients with long-term DPN who might be found in primary and secondary care. VAS.3) 4. Acupunct Med 2014.32:242–249.

13 It has previously been suggested that nonpenetrating sham needles could cause some level of sensory stimulation when the needles are tapped and rotated and therefore stimulate the acupuncture on June 5. This result may occur because the BPS items relate to general pain changes in the Garrow AP. doi:10. 2014 . Acupunct Med 2014.32:242–249.33 In a post hoc analysis 3 months after their final treatment. which shows only small changes in eight of the nine outcome measures in the sham group between baseline and 10 weeks. participants were asked whether they thought they had received active or sham treatment. it is unlikely. however. the sample size was too small for the observed differences between groups to appear statistically significant. over 90% of patients had loss of sharp/blunt and light touch sensation in their lower limbs (table 1). that the study patients would have been able to differentiate between real or sham needles. et al. These data suggest that our results were not unduly biased owing to any blinding effects. but not in the sham group. The exception to this was the SF-36 BPS.bmj.Published by group. Observed improvements in the active acupuncture group. treatment effects.Downloaded from aim. results which suggest that the sham treatment was relatively therapeutically Original paper Figure 2 Flow chart of patients through the trial. The study included only 59 participants and therefore some of the results may be susceptible to type II errors —that is. suggest that acupuncture may have a role in the treatment of some of the unpleasant symptoms associated with DPN. Evidence for this is provided in table 2. Our findings showing small to moderate treatment effects of active acupuncture are comparable with randomised studies of headache and low back pain. therefore. which showed a small six-unit improvement over 10 weeks.bmj. Forty per cent in the active acupuncture group thought they had received sham treatment and 42% in the sham group thought they received real treatment.36 In this study.34 35 246 The results are also consistent with the findings of a recent systematic review of the analgesic effects of acupuncture in chronic pain.1136/acupmed-2013-010495 .

1) −15 (−26 to −3.2) SF-36 physical component score Baseline 32.5) −5.3 (−4.3) Original paper Table 2 Changes in outcomes between baseline and 10-weeks group differences (mean and SD) Outcome measures Sham Active Difference (95% CI) LANNS scores Baseline 15.7 to 1.8) 10-Week follow-up 75 (9.7) 2.6 to 1.4) −2.5 to 1.4 (−7.0) 0.4) −0.9) 40. were reported in the findings of a systematic review of 11 studies.5) 7 (−4 to 19) MYMOP scores Baseline 4.05) Change score (95% CI) −0.8 to 8.3) Change score (95% CI) 1.Downloaded from aim.7) Change score (95% CI) −0.4 10-Week follow-up 35.4 (−12.4 (1. future studies should collect information on the different signs and symptoms associated with DPN rather than concentrating on detecting unit reductions in pain intensity.4) 10.71) 10-Week follow-up 4.8 to 17.7 (−6.2) 0.3) 6. however.6) −1.9 to 0.77) Change score (95% CI) −0.3) −0. Although the attendance was in line with expectations.2 to 5.bmj.2 (1.2 (−10.89 (−1.16 (−5.1 (−5.82) 2.5) Change score (95% CI) −0.2) 6.5 (−3.3) 4.7 (12.3 (−4.4) 70 (10.85 (0.7) −3.2 (6.2 (−4.7 to 10.2) −5.43 to 0.2 (7.2 (7.8) Results are shown as mean (SD) or mean (95% CI). Similar on June 5.4) Sleep Problem Scale Baseline 13.3 (6. 2014 .4) Resting systolic BP Baseline 132 (17.8 (6.1 (12.9 (20.2) −0.5 to 1.6 (8.4) 9. Acupunct Med 2014.3) 0.4) 40.3 to 11.7 to 3.38 Although our results should be treated with caution.7) 75 (9.7) 133. in future studies we would recommend the adoption of additional measures to reduce the non-attendance rate.0 to 2.4 to −0.7 (13.1 to 7. Garrow AP.7 (27.5 (−4.2 (−5. previous month and therefore BPS is likely to reflect the episodic nature of chronic musculoskeletal pain commonly found in people of this age.7 to 3.03 (−0.2 (1.7 (0.1 (−2.8 to 8.58 to 0.2 (7.1 to 5.1 (−1.8 (14.74) −5.1) Change score (95% CI) −2.1 (9.6 (−2.5 to 2.1 to 1. BP.4) Resting diastolic BP Baseline 77 (8.4) Change score (95% CI) 6. 247 .14) 4.1) 12.5) SF-36 mental component score Baseline 36. Measure Yourself Medical Outcome Profile.5 (10.8 to 10. VAS.3 to 5.97 (−4.8) SF-36 bodily pain score Baseline 27.7) 1.4 (−6.1 to 22.3 (1. LANNS.6) 39. they do support the inclusion of blood pressure as an outcome in future acupuncture studies. MYMOP.bmj.5 to 2.2) 4.5) 2.5 to 2.7) 1.1 to 0.1136/acupmed-2013-010495 This study has shown that acupuncture can be successfully incorporated into the management of patients with DPN.7) −1.4 to 4.2) VAS scores Baseline 67 (19) 73 (24) 6 (−5 to −17) 10-Week follow-up 62 (23) 58 (26) −4 (−17 to 9) Change score (95% CI) −5 (−11 to 1.7 (−1.7 to 17. Blood Pressure.32:242–249.1) −0. et al.4 to −0. As our results suggested improvements in a variety of troublesome symptoms.3 to 1.0) 3.1 (−1.9 (9.1 (−3.5 (−5.1 to 9.4 to 1. such as the use of reminder texts and telephone calls.67 (−2.Published by group.6 (−6.8) 31. doi:10.6 (7.6 to 10.2 to −0.07 (−0.1) 3.8 (−1.8) −0.3 (19.7 (16.4 to −0.2 to 0.19) Change score (95% CI) −0.42 (−3.8 (−7.37 Our results also suggest that the 10-week course of acupuncture may lead to a 5 mm Hg reduction in diastolic blood pressure. Visual Analogue Scale.2) −2.6) 10-Week follow-up 16.5 (−5.2 (−10. Leeds Assessment of Neuropathic Symptoms and Signs.6) 10-Week follow-up 13.2) 2.06 (−2. SF-36.9) −2.2 (20.2 (−10.3) 10-Week follow-up 33. Short Form 36.003 (−0.42) −0.6) 138 (14.2) 13.6 (−0.2 (14.9 (−4.7 (−6.2) 1.8 to 5.1) 10-Week follow-up 131.0) 10-Week follow-up 31. The evidence for the efficacy of acupuncture in controlling blood pressure is controversial and inconclusive.6 (−2.9) −2.7 to 15.0) 14.3 (6.9) 37.4 to −0.

APG produced draft copies of the manuscript and the final version for submission. Manni L. Schröder S.(3):CD007938. Freeman R. 16 Garrow AP. White A. Garrow AP. Acupuncture for chronic pain: individual patient data meta-analysis. MYMOP. Al-Khafaji M.5 (−3. Derry S. ▸ Improvements in symptoms were promising. The findings of this study will be useful in the planning of larger RCTs that are needed to determine the therapeutic and cost-effectiveness of acupuncture in the treatment of DPN. Fifteen-day acupuncture treatment relieves diabetic peripheral Original paper Table 3 Standardised mean difference (effect size) comparing active acupuncture with sham acupuncture at the 10 week visit Outcome measures Standardised mean differences 95% CI MYMOP −0. Cronin AM.39:115–21. Streitberger K. Correction notice This article has been corrected since it was published Online First. England J. Diabetes Res Clin Pract 1998. 2014 .83:235–41.30 (−4.2 to 1. et al.4) Lower limb VAS −0. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology. Yang G-Y.99) Sleep Problem Scale −0. van Ross ER. Contributors All authors contributed to the design of the pilot RCT. Vibration perception threshold–a valuable assessment of neural dysfunction in people with diabetes. ▸ We tested the feasibility of a sham-controlled acupuncture trial. Diabetes Metab Res Rev 2006.22 (−2.22:411–19. Gabapentin for chronic neuropathic pain and fibromyalgia in adults.35) Resting diastolic blood pressure −0. Acupunct Med 2014. Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: a long-term study.08 (−4. Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial.19:377–84. Visual Analogue Scale. et al. The diabetic foot: from art to science.6) LANSS. Measure Yourself Medical Outcome Profile. 7 Savigny P. Randomised clinical trial comparing the effects of acupuncture and a newly designed placebo needle in rotator cuff tendinitis.25:11–17. The 18th Camillo Golgi lecture. Short Form 36.Downloaded from aim.37 (−2. J Acupunct Med 2011.32:242–249. doi:10. 19 Deadman P. 11 Chen on June 5.9 to 5. SF-36. Boulton AJ. CA 92081. JAMA 1998. Early management of persistent nonspecific low back pain: summary of NICE guidance. Evid Based Complement Alternat Med 2013. USA. Costanzi JB. new diabetic foot ulceration in a community-based patient cohort. 17 Donald GK.4) SF-36 physical component score 0. 2nd edn. 15 Tan LS. Two styles of acupuncture for treating painful diabetic neuropathy—a pilot randomised control trial.6) SF-36 bodily pain score 0. Figure 1 has been amended.11:1590–5. 3 Boulton AJ. Baker K. 2003. Neurology 2001. BMJ 2009. Validating a new non-penetrating sham acupuncture device: two randomised controlled trials.22:681–5.47:1343–53. et al.3:95–103. The clinical use of the 10 g monofilament and its limitations: a review.6 to 4. Summary points ▸ Painful diabetic neuropathy is difficult to treat.1) Resting systolic blood pressure 0. 10 Ahn AC.bmj. 5 Bril V. Provenance and peer review Not commissioned. Wiffen PJ. Leeds Assessment of Neuropathic Symptoms and Signs. Maschino AC.1 to 3. Bennani T. The views expressed are those of the author(s) and not necessarily those of the NHS. Max MB. ▸ Patients were willing and standardised treatment was deliverable in the diabetic clinic. Chaloner K.7) SF-36 mental component score 0.90:1–7.51 (−2. Han B.16 (−6. VAS.K. Manual acupuncture for treatment of diabetic peripheral neuropathy: a systematic review of randomized controlled trials. and a trial feasible.8: e73764.96 to −0. Stringer J. Watson P. externally peer reviewed. and the American Academy of Physical Medicine and Rehabilitation. The North-West Diabetes Foot Care Study: incidence of. et al. Tobin I.172:1444–53. All other authors contributed and approved the final version of the manuscript. A systematic review of experimental and clinical acupuncture in chemotherapyinduced peripheral neuropathy. et al. Franklin GM. Windeler J. Stevinson C. et al. et al. et al. 20 Park J. et al. Guo H. Boulton AJ. Vista: Eastland Press. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U. 13 Vickers AJ. the American Association of Neuromuscular and Electrodiagnostic Medicine. and risk factors for. Liu B.4:345–52. et al. 6 Kleinhenz J. Terry Beirn Community Programs for Clinical Research on AIDS. Carrington AL. 4 Moore RA. Gore M. Clin J Pain 2006. Diabetes Care 2011. Diabetologia 2004. 12 Franconi G.2 to 1. EBJ is guarantor of the paper taking responsibility for the integrity of the work as a whole from inception to published article.29:230–3. Acupunct Med 2007.bmj.1136/acupmed-2013-010495 .34:2220–4. et al. Evaluation of acupuncture in the management of chemotherapy-induced peripheral neuropathy.20:168–74. Malik RA. Acupunct Med 2002. Pain 1999. Sleep impairment in patients with painful diabetic peripheral neuropathy. Ashe H. Funding This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme (grant reference number PBPG-0706-10595). 18 Shlay JC.338:b1805. Brandenburg NA.Published by group.66 (−0.0 to 1. the NIHR or the Department of Health. PLoS ONE 2013.4 to 6. Diabetes Res Clin Pract 2010. 248 2 Zelman DC. Cochrane Database Syst Rev 2011. Ethics approval Ethical approval was obtained from the north west ethics committee (ref: 08/H1011/16A).2013:1–7. 8 Abuaisha BB. Manual of acupuncture. REFERENCES 1 Abbott CA. Arch Intern Med 2012. Underwood M. et al.26 (−3.16) LANSS pain scale −0. APG and EBJ performed the statistical analysis. Competing interests None. 9 Tong Y. J Acupunct Meridian Stud 2010. Diabet Med 2002. 14 Abbott CA. ISRCTN number: 39740785.2 to 2.

32 MacPherson H. A longitudinal study of joint pain in older people. Acupuncture in patients with chronic low back pain: a randomized controlled trial. 23 Solak O. Kim SY. Foy C. 249 .1136/acupmed-2013-010495 31 Linde K. BMJ 2008.17:259–64. Deqi sensations without cutaneous sensory input: results of an RCT. Altman DG. Niemcryk SJ. Arch Intern Med 2006. Gluud LL. Williamson PR. Am J Hypertens 2009. Trials 2013.323:1123–4. MYMOP. BMJ 2001. et al. Linde on June 5. Egger M. Simang M. Stanton BA. Design and analysis of pilot studies: recommendations for good practice. Forsch Komplementarmed Klass Naturheilkd 2003. et al.336:601–5. Altman DG. Circulation 2007.166:450–7. STRICTA Revision Group. Esme H.22:122–8. 2014 . Sherbourne CD. 30 Vickers AJ. Pain 2001. Zhao L. J Evid Based Med 2010.bmj.10:2–9. Measuring outcomes in primary care: a patient generated measure. Med Care 1992. 34 Melchart D. 28 Li J. How large are the nonspecific effects of acupuncture? A metaanalysis of randomized controlled trials. Randomized trial of acupuncture to lower blood pressure. BMC Complement Altern Med 2010. 24 Paterson C. J Clin Epidemiol 1988. Niemann K. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT statement. Witt CM.10:179–84. Zheng H.41:313–21. et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. Eur J Cardiothorac Surg 2007. 26 Ware JE Jr. BMJ 1996. 33 Wood L. 27 Flachskampf FA.. 36 Linde K. et al.Published by group. Dodd S. Garrow AP. A scale for the estimation of sleep problems in clinical research. J Eval Clin Pract 2004.14:1–10. Streng A.bmj. Rheumatology (Oxford) 2004. et al.43:1256–60. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs.115:3121–9. et al. Acupuncture Randomized Trials (ART) in patients with migraine or tension-type headache--design and protocols. et al. Gallasch J. et al. Are sham acupuncture interventions more effective than (other) placebos? A re-analysis of data from the Cochrane review on placebo effects. 29 Lancaster GA. Bäumler P.32:242–249.10:307–12. Acupunct Med 2014. BMC Med 2010. 38 Lee H. Gefeller O. Forsch Komplementmed 2010.312:1016–20. et al. 22 Bennett M. et al. et al. Meissner K. 35 Brinkhaus B.8:75. Acupuncture for lowering blood pressure: systematic review and Original paper 21 Salih N.92:147–57. doi:10. Schneider A. Statistics notes: analysing controlled trials with baseline and follow up measurements. Effectiveness of gabapentin in the treatment of chronic post-thoracotomy pain. 25 Jenkins CD. Niemann K. Park J. compared with the SF-36 health survey. Hammerschlag R. Jena S. Acupuncture for patients with mild hypertension: study protocol of an open-label multicenter randomized controlled trial.30:473–83. 37 Donald IP.Downloaded from aim. The MOS 36-item short-form health survey (SF-36).3:140–55. Metin M. Conceptual framework and item selection.32:9–12.

Further reproduction prohibited without permission. .Reproduced with permission of the copyright owner.

Master your semester with Scribd & The New York Times

Special offer for students: Only $4.99/month.

Master your semester with Scribd & The New York Times

Cancel anytime.